• SORRENTO COLLABORATES WITH MABPHARM ON DEVELOPMENT AND COMMERCIALIZATION OF ACE-MAB™ TO POTENTIALLY TREAT COVID-19

    6 days ago - By San Diego Biotechnology

    SAN DIEGO, March 24, 2020 - Sorrento Therapeutics, Inc. today announced it has entered into an exclusive license agreement with China-based antibody biopharmaceutical company, Mabpharm Limited (Hong Kong S......
    Read more ...